Ovation Science Inc (TSE:OVAT)
:OVAT
Want to see TSE:OVAT full AI Analyst Report?
OVAT Stock Chart & Stats
C$0.04
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.04
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.06
Previous CloseN/A
Volume0.00
Average Volume (3M)3.74K
Market Cap
C$1.06M
Enterprise ValueC$1.01M
Total Cash (Recent Filing)C$72.29K
Total Debt (Recent Filing)C$283.06K
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Jun 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding35,244,682
10 Day Avg. Volume3,400
30 Day Avg. Volume3,744
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)-0.98
Price to Sales (P/S)20.98
P/FCF Ratio-18.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary Delivery PlatformA proprietary transdermal platform provides a durable competitive edge: it supports differentiated finished products across cosmetic and therapeutic segments, creates higher switching costs versus commodity topical formulations, and can underpin licensing or co-development revenue over multiple product cycles.
Multiple Monetization PathwaysThe ability to monetize the technology both through finished-product sales (DTC/wholesale) and potential B2B licensing/partnerships offers structural diversification. Licensing can scale revenue with lower capital needs and create recurring fees if partners adopt the platform long-term.
Improving Cash-burn TrendAn improving cash-burn trajectory versus earlier years indicates management has begun to stem outflows or right-size operations. If sustained, this trend lengthens runway, reduces near-term funding dependence, and increases the chance of reaching cash-flow breakeven over a multi-quarter horizon.
Bears Say
Negative Shareholders' EquitySustained negative equity signals accumulated losses exceeding capital, constraining financial flexibility. It limits borrowing options, can complicate supplier and partner relationships, and increases dilution or restructuring risk if the company must raise capital to continue operations.
Persistent Operating Cash BurnConsistent negative operating and free cash flow means the business cannot self-fund operations or growth. Over the medium term this creates ongoing dependence on external financing or asset sales, heightening execution risk and the chance of disrupted operations if capital becomes scarce.
Declining Revenue And Negative MarginsSharp multi-year revenue decline and a gross loss in 2025 indicate weak commercial traction and margin instability. Without stable top-line growth and positive gross margins, sustained profitability is unlikely and it becomes difficult to leverage fixed costs or scale the business profitably.
Ovation Science News
OVAT FAQ
What was Ovation Science Inc’s price range in the past 12 months?
Ovation Science Inc lowest stock price was C$0.03 and its highest was C$0.06 in the past 12 months.
What is Ovation Science Inc’s market cap?
Ovation Science Inc’s market cap is C$1.06M.
When is Ovation Science Inc’s upcoming earnings report date?
Ovation Science Inc’s upcoming earnings report date is Jun 01, 2026 which is in 11 days.
How were Ovation Science Inc’s earnings last quarter?
Currently, no data Available
Is Ovation Science Inc overvalued?
According to Wall Street analysts Ovation Science Inc’s price is currently Overvalued.
Does Ovation Science Inc pay dividends?
Ovation Science Inc does not currently pay dividends.
What is Ovation Science Inc’s EPS estimate?
Ovation Science Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ovation Science Inc have?
Ovation Science Inc has 35,244,682 shares outstanding.
What happened to Ovation Science Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ovation Science Inc?
Currently, no hedge funds are holding shares in TSE:OVAT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ovation Science Inc
Ovation Science Inc. engages in the production of cannabis or hemp products in Canada, the United States, and Mexico. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin care products containing hemp seed oil and cannabis under the Ovation and BASKiN brands. It offers cannabidiol infused health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and hand sanitizers under the DermSafe name. The company holds sublicenses for cannabis based products; and Lighthouse for licensed dispensaries in the United States. Ovation Science Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Technical Analysis
Willow Biosciences Inc
―
MediPharm Labs
―
Nextleaf Solutions
―
Vext Science
―
BioNxt Solutions
―